Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo
Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo have?
Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo has 161 citations in the OpenAlex counts ScholarIQ stores.
When was Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo published?
Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo has 2014 year in the ScholarIQ index.
What is the open-access status of Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo?
Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo has gold oa status in the ScholarIQ index.
What is the DOI of Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo?
The DOI for Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo is on the source record.
What is the PMID of Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo?
The PMID for Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo is on the source record.
What is the OpenAlex record for Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo?
The OpenAlex for Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo is on the source record.